Pre-Test: Self Assessment Quiz - The Value of IHC in Melanocytic Tumor Pathology

The Value of IHC in Melanocytic Tumor Pathology

This session will discuss the use of immunohistochemistry in the diagnosis of melanocytic tumors.

At the end of the session, participants will be able to:

1. Provide an overview of the complex challenges in diagnostic melanocytic tumor pathology
2. Discuss the benefit of individual immunohistochemical markers in specific diagnostic settings

Speakers: Dr. Thomas Brenn
Target audience: Pathologists
CanMEDS Roles: Medical Expert (the integrating role)

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Association of Pathologists. You may claim a maximum of 1.5 hours (credits are automatically calculated).

This program is an accredited self‐assessment program (section 3) as defined by the maintenance of certification program of the royal college of physicians & surgeons of Canada and approved by the Canadian association of Pathologists. You may claim a maximum of 0.5 hours (credits are automatically calculated)

To qualify for Section 3
You must complete both the Pre-Test and Post-Test Self Assessment Questions and attend the webinar to qualify for 0.5 hour of Section 3 MOC and 1 hour of Section 1 MOC. 

Otherwise, you can only claim, and receive a certificate, Section 1 participation.